133 related articles for article (PubMed ID: 11830511)
1. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
2. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
3. The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells.
Taverniti V; Krynska H; Venuti A; Straub ML; Sirand C; Lohmann E; Romero-Medina MC; Moro S; Robitaille A; Negroni L; Martinez-Zapien D; Masson M; Tommasino M; Zanier K
mSphere; 2023 Apr; 8(2):e0005623. PubMed ID: 36883841
[TBL] [Abstract][Full Text] [Related]
4. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.
Zhao L; Hsiao T; Stonesifer C; Daniels J; Garcia-Saleem TJ; Choi J; Geskin L; Rook AH; Wood GS
J Invest Dermatol; 2022 Dec; 142(12):3253-3261.e4. PubMed ID: 35787399
[TBL] [Abstract][Full Text] [Related]
5. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.
Aqeilan RI; Pekarsky Y; Herrero JJ; Palamarchuk A; Letofsky J; Druck T; Trapasso F; Han SY; Melino G; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4401-6. PubMed ID: 15070730
[TBL] [Abstract][Full Text] [Related]
6. Measles virus V protein inhibits p53 family member p73.
Cruz CD; Palosaari H; Parisien JP; Devaux P; Cattaneo R; Ouchi T; Horvath CM
J Virol; 2006 Jun; 80(11):5644-50. PubMed ID: 16699046
[TBL] [Abstract][Full Text] [Related]
7. DeltaN-p73alpha accumulates in human neuroblastic tumors.
Douc-Rasy S; Barrois M; Echeynne M; Kaghad M; Blanc E; Raguenez G; Goldschneider D; Terrier-Lacombe MJ; Hartmann O; Moll U; Caput D; Bénard J
Am J Pathol; 2002 Feb; 160(2):631-9. PubMed ID: 11839584
[TBL] [Abstract][Full Text] [Related]
8. Dichotomous transactivation domains contribute to growth inhibitory and promotion functions of TAp73.
Li D; Kok CYL; Wang C; Ray D; Osterburg S; Dötsch V; Ghosh S; Sabapathy K
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2318591121. PubMed ID: 38739802
[TBL] [Abstract][Full Text] [Related]
9. Isoform-specific disruption of the
Kong X; Yan W; Sun W; Zhang Y; Yang HJ; Chen M; Chen H; de Vere White RW; Zhang J; Chen X
Elife; 2023 Aug; 12():. PubMed ID: 37650871
[No Abstract] [Full Text] [Related]
10. Expression of TAp73α affects the therapy effect of chemotherapy drugs in gastric cancer.
Qiang L; Ji Z; Wang X
Oncol Res; 2018 Jan; ():. PubMed ID: 29362023
[TBL] [Abstract][Full Text] [Related]
11. The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.
Ando K; Nakagawara A
Cells; 2023 Feb; 12(4):. PubMed ID: 36831211
[TBL] [Abstract][Full Text] [Related]
12. p53 Family in Resistance to Targeted Therapy of Melanoma.
Vlašić I; Horvat A; Tadijan A; Slade N
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613518
[TBL] [Abstract][Full Text] [Related]
13. Structural diversity of p63 and p73 isoforms.
Osterburg C; Dötsch V
Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
[TBL] [Abstract][Full Text] [Related]
14. p73 as a Tissue Architect.
Maeso-Alonso L; López-Ferreras L; Marques MM; Marin MC
Front Cell Dev Biol; 2021; 9():716957. PubMed ID: 34368167
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific expression of p73 and p63 isoforms in human tissues.
Marshall CB; Beeler JS; Lehmann BD; Gonzalez-Ericsson P; Sanchez V; Sanders ME; Boyd KL; Pietenpol JA
Cell Death Dis; 2021 Jul; 12(8):745. PubMed ID: 34315849
[TBL] [Abstract][Full Text] [Related]
16. p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies.
Horvat A; Tadijan A; Vlašić I; Slade N
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207603
[TBL] [Abstract][Full Text] [Related]
17. Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors.
Omran Z; H Dalhat M; Abdullah O; Kaleem M; Hosawi S; A Al-Abbasi F; Wu W; Choudhry H; Alhosin M
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921128
[TBL] [Abstract][Full Text] [Related]
18. TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation.
Iscan E; Ekin U; Yildiz G; Oz O; Keles U; Suner A; Cakan-Akdogan G; Ozhan G; Nekulova M; Vojtesek B; Uzuner H; Karakülah G; Alotaibi H; Ozturk M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668566
[TBL] [Abstract][Full Text] [Related]
19. Role of Antizyme Inhibitor Proteins in Cancers and Beyond.
Tulluri V; Nemmara VV
Onco Targets Ther; 2021; 14():667-682. PubMed ID: 33531815
[TBL] [Abstract][Full Text] [Related]
20. Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency.
Francies FZ; Bassa S; Chatziioannou A; Kaufmann AM; Dlamini Z
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
